A Phase 1, Single-center, Open-label, 2-period, Single Sequence Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose Rifampicin on the Pharmacokinetics and Pharmacodynamics of Single Dose Sotagliflozin in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Sotagliflozin (Primary) ; Rifampicin
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 04 May 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 28 Feb 2017 New trial record